Global Protein Therapeutics Market to Cross US$ 143 Billion-mark by 2015

(prHWY.com) April 9, 2012 - NOIDA, India -- Therapeutics Market Forecast to 2015", provides in-depth research and rational analysis of the current status and expected position of the Global Protein Therapeutics Market. It facilitates forecasts for the market, projecting the potential to be generated by protein-based therapies, which are in the pipeline. The comprehensive research analyzes the opportunities for companies in the market, in terms of key countries and leading indications. The report includes the analysis of the advanced protein therapeutics products under development and the recent developments to provide a balanced outlook on the market potentials.

Some of the key findings of the report are:

- Monoclonal Antibodies (mAbs) will dominate protein-based therapies market.
- Commercialization of protein therapeutics in pipeline will impact the market's future performance.
- Coagulation factor will boost the market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM389.htm

Some of our Related Reports are:

- Cancer Monoclonal Antibodies Market to 2015 (http://www.rncos.com/Report/IM375.htm)
- Global Biosimilars Market Forecast to 2015 (http://www.rncos.com/Report/IM379.htm)
- US Biotech Market Analysis (http://www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (http://www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (http://www.rncos.com/Report/IM361.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###